Last reviewed · How we verify
sucrose 5%
At a glance
| Generic name | sucrose 5% |
|---|---|
| Also known as | sucrose sugar |
| Sponsor | Rambam Health Care Campus |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- pH1N1 Blinded Challenge Study (PHASE1)
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M (PHASE2)
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region. (PHASE2)
- Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis (PHASE3)
- Sugars in Cigarettes (NA)
- Evaluation of Pine Bark Extract for Anti-fatigue Ergogenic Properties (NA)
- ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (PHASE1)
- Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sucrose 5% CI brief — competitive landscape report
- sucrose 5% updates RSS · CI watch RSS
- Rambam Health Care Campus portfolio CI